- Home
- SMTI vs ELDN Comparison
SMTI vs ELDN Comparison
Compare SMTI & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMTI | ELDN |
|---|---|---|
| Founded | 1982 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 208.6M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SMTI | ELDN |
|---|---|---|
| Price | $20.56 | $2.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $41.00 | $8.50 |
| AVG Volume (30 Days) | 61.0K | ★ 632.3K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,586,976.00 | N/A |
| Revenue This Year | $20.66 | N/A |
| Revenue Next Year | $17.21 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $18.29 | $1.35 |
| 52 Week High | $35.70 | $4.60 |
Technical Indicators
Market Signals| Indicator | SMTI | ELDN |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 72.32 |
| Support Level | $20.12 | $2.59 |
| Resistance Level | $26.48 | $2.77 |
| Average True Range (ATR) | 1.05 | 0.15 |
| MACD | 0.20 | 0.05 |
| Stochastic Oscillator | 71.28 | 92.41 |
Price Performance
Historical ComparisonAbout SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.